You are here

Meeting Highlights

San Antonio Breast Cancer Symposium

Walter Alexander
PDF version: 
Presentations cover a short course of treatment with capecitabine (Xeloda), docetaxel (Taxotere), and trastuzumab (Herceptin); a study of the aromatase inhibitors letrozole (Femara) and zoledronic acid (Zometa) and their effect on bone loss; the aromatase inhibitors and tamoxifen (Nolvadex); and a trial of capecitabine plus ixabepilone (Ixempra) compared with ixabepilone monotherapy.